Expressing:Article Title: CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway
Article Snippet: Membranes were blocked with 5% skimmed milk at room temperature for 1.5 h, followed by incubation with primary antibodies overnight at 4°C.. The primary antibodies used were: CDC5L (cat. no. 12974-1-AP; 1:1,000; Proteintech Group, Inc.), GSDME (cat. no. ab215191; 1:1,000; Abcam), GSDME-N (cat. no. ab222408; 1:1,000; Abcam), Caspase-7 (cat. no. ab25900; 1:1,000; Abcam), Caspase-9 (cat. no. ab2013; 1:2,000; Abcam), Caspase-6 (cat. no. ab52951; 1:20,000; Abcam Plc), Caspase-8 (cat. no. ab227430; 1:1,000; Abcam), Caspase-1 (cat. no. ab286125; 1:1,000; Abcam), Caspase 3 (cat. no. 19677-1-AP; 1:1,000; Proteintech Group, Inc.), Caspase-10 (cat. no. ab2012; 1:2,000; Abcam), KHDRBS1 (cat. no. 10222-1-AP; 1:3,000; Proteintech Group, Inc.), NUDT21 (cat. no. 10322-1-AP; 1:5,000; Proteintech Group, Inc.), HNRNPA2B1 (cat. no. 67445-1-Ig; 1:8,000; Proteintech Group, Inc.), RBMX (cat. no. ab250272; 1:1,000; Abcam), HNRNPC (cat. no. ab133607; 1:20,000; Abcam), ELAVL1 (cat. no. ab238528; dilution, 1:1,000; Abcam) and β-actin (cat. no. AWA80002 ; 1:5,000; Changsha Abiowell Biotechnology Co., Ltd.).. Membranes were incubated with HRP goat anti-mouse/rabbit IgG (cat. no. SA00001-1/SA00001-2; 1:5,000/1:6,000; Proteintech Group, Inc.) at room temperature for 1.5 h. Next, membranes were treated with an ECL reagent (cat. no. AWB0005, Changsha Abiowell Biotechnology Co., Ltd.) for 1 min and then subjected to analysis using an imaging system (Bio-Rad ChemiDoc MP, Bio-Rad Laboratories, Inc.).
Reverse Transcription Polymerase Chain Reaction:Article Title: CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway
Article Snippet: Membranes were blocked with 5% skimmed milk at room temperature for 1.5 h, followed by incubation with primary antibodies overnight at 4°C.. The primary antibodies used were: CDC5L (cat. no. 12974-1-AP; 1:1,000; Proteintech Group, Inc.), GSDME (cat. no. ab215191; 1:1,000; Abcam), GSDME-N (cat. no. ab222408; 1:1,000; Abcam), Caspase-7 (cat. no. ab25900; 1:1,000; Abcam), Caspase-9 (cat. no. ab2013; 1:2,000; Abcam), Caspase-6 (cat. no. ab52951; 1:20,000; Abcam Plc), Caspase-8 (cat. no. ab227430; 1:1,000; Abcam), Caspase-1 (cat. no. ab286125; 1:1,000; Abcam), Caspase 3 (cat. no. 19677-1-AP; 1:1,000; Proteintech Group, Inc.), Caspase-10 (cat. no. ab2012; 1:2,000; Abcam), KHDRBS1 (cat. no. 10222-1-AP; 1:3,000; Proteintech Group, Inc.), NUDT21 (cat. no. 10322-1-AP; 1:5,000; Proteintech Group, Inc.), HNRNPA2B1 (cat. no. 67445-1-Ig; 1:8,000; Proteintech Group, Inc.), RBMX (cat. no. ab250272; 1:1,000; Abcam), HNRNPC (cat. no. ab133607; 1:20,000; Abcam), ELAVL1 (cat. no. ab238528; dilution, 1:1,000; Abcam) and β-actin (cat. no. AWA80002 ; 1:5,000; Changsha Abiowell Biotechnology Co., Ltd.).. Membranes were incubated with HRP goat anti-mouse/rabbit IgG (cat. no. SA00001-1/SA00001-2; 1:5,000/1:6,000; Proteintech Group, Inc.) at room temperature for 1.5 h. Next, membranes were treated with an ECL reagent (cat. no. AWB0005, Changsha Abiowell Biotechnology Co., Ltd.) for 1 min and then subjected to analysis using an imaging system (Bio-Rad ChemiDoc MP, Bio-Rad Laboratories, Inc.).
|